Literature DB >> 32918818

Social norms for e-cigarettes and smoking: associations with initiation of e-cigarette use, intentions to quit smoking and quit attempts: findings from the EUREST-PLUS ITC Europe Surveys.

Máirtín S McDermott1, Katherine A East1,2, Sara C Hitchman1,2, Ann McNeill1,2, Yannis Tountas3, Tibor Demjén4, Esteve Fernández5,6,7, Ute Mons8, Antigona C Trofor9,10, Aleksandra Herbeć11,12, Kinga Janik-Koncewicz11, Geoffrey T Fong13,14, Constantine I Vardavas15,16,17.   

Abstract

BACKGROUND: Social norms have received little attention in relation to electronic cigarettes (EC). The current study examine social norms for EC use and smoking tobacco, and their associations with (i) initiation of EC use, (ii) intention to quit smoking and (iii) attempts to quit smoking.
METHODS: Cross-sectional and longitudinal data analysis from Waves 1 and 2 of the ITC 6 European Country Survey and corresponding waves from England (the ITC Four Country Smoking and Vaping Survey). Current smokers at baseline, who heard of ECs and provided data at both waves were included (n = 3702). Complex samples logistic regression examined associations between the outcomes and descriptive (seeing EC use in public, close friends using ECs/smoking) and injunctive (public approves of ECs/smoking) norms, adjusting for country, demographics, EC use and heaviness of smoking.
RESULTS: In longitudinal analyses, seeing EC use in public at least some days was the only social norm that predicted initiation of EC use between waves (OR = 1.66, 95%CI = 1.08-2.56). In the cross-sectional analysis, having an intention to quit was associated with seeing EC use in public (OR = 1.37, 95%CI = 1.04-1.81) and reporting fewer than three close friends smoke (OR = 0.59, 95%CI = 0.44-0.80). There was no association between any social norm and making a quit attempt between waves.
CONCLUSIONS: Initiation of EC use is predicted by seeing EC use in public, which was also associated with greater intention to quit smoking. Friends' smoking was associated with lower intention to quit. These findings may allay concerns that increased visibility of ECs is renormalizing smoking amongst current smokers.
© The Author(s) 2020. Published by Oxford University Press on behalf of the European Public Health Association. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 32918818      PMCID: PMC7526789          DOI: 10.1093/eurpub/ckaa014

Source DB:  PubMed          Journal:  Eur J Public Health        ISSN: 1101-1262            Impact factor:   3.367


  26 in total

1.  Predicting the intention to quit smoking and quitting behaviour: extending the theory of planned behaviour.

Authors:  J Rise; V Kovac; P Kraft; I S Moan
Journal:  Br J Health Psychol       Date:  2007-03-05

2.  A longitudinal test of the theory of planned behavior predicting smoking onset among asthmatic and non-asthmatic adolescents.

Authors:  Monique O M Van De Ven; Rutger C M E Engels; Roy Otten; Regina J J M Van Den Eijnden
Journal:  J Behav Med       Date:  2007-06-30

3.  The renormalization of smoking? E-cigarettes and the tobacco "endgame".

Authors:  Amy L Fairchild; Ronald Bayer; James Colgrove
Journal:  N Engl J Med       Date:  2013-12-18       Impact factor: 91.245

4.  The effects of smoking self-identity and quitting self-identity on attempts to quit smoking.

Authors:  Bas van den Putte; Marco Yzer; Marc C Willemsen; Gert-Jan de Bruijn
Journal:  Health Psychol       Date:  2009-09       Impact factor: 4.267

Review 5.  Predictors of the Onset of Cigarette Smoking: A Systematic Review of Longitudinal Population-Based Studies in Youth.

Authors:  Robert J Wellman; Erika N Dugas; Hartley Dutczak; Erin K O'Loughlin; Geetanjali D Datta; Béatrice Lauzon; Jennifer O'Loughlin
Journal:  Am J Prev Med       Date:  2016-05-11       Impact factor: 5.043

6.  Electronic Cigarette and Cigarette Social Environments and Ever Use of Each Product: A Prospective Study of Young Adults in Southern California.

Authors:  Robert Urman; Rob McConnell; Jennifer B Unger; Tess B Cruz; Jonathan M Samet; Kiros Berhane; Jessica L Barrington-Trimis
Journal:  Nicotine Tob Res       Date:  2019-09-19       Impact factor: 4.244

7.  PREVALENCE AND PREDICTORS OF E-CIGARETTE TRIAL AMONG ADOLESCENTS IN ARGENTINA.

Authors:  Paola Morello; Adriana Pérez; Lorena Peña; Paula Lozano; James F Thrasher; James D Sargent; Raúl Mejía
Journal:  Tob Prev Cessat       Date:  2016-12

8.  Social norms towards smoking and electronic cigarettes among adult smokers in seven European Countries: Findings from the EUREST-PLUS ITC Europe Surveys.

Authors:  Katherine A East; Sara C Hitchman; Mairtin McDermott; Ann McNeill; Aleksandra Herbeć; Yannis Tountas; Nicolas Bécuwe; Tibor Demjén; Marcela Fu; Esteve Fernández; Ute Mons; Antigona C Trofor; Witold A Zatoński; Geoffrey T Fong; Constantine I Vardavas
Journal:  Tob Induc Dis       Date:  2019-03-22       Impact factor: 2.600

9.  Factors associated with future intentions to use personal vaporisers among those with some experience of vaping.

Authors:  Bernice Hua Ma; Hua-Hie Yong; Ron Borland; Ann McNeill; Sara C Hitchman
Journal:  Drug Alcohol Rev       Date:  2017-05-31

10.  Harm perceptions of electronic cigarettes and nicotine: A nationally representative cross-sectional survey of young people in Great Britain.

Authors:  Katherine East; Leonie S Brose; Ann McNeill; Hazel Cheeseman; Deborah Arnott; Sara C Hitchman
Journal:  Drug Alcohol Depend       Date:  2018-10-02       Impact factor: 4.492

View more
  2 in total

1.  Evaluating the impact of the Tobacco Products Directive within the context of the FCTC in Europe-findings from the EUREST-PLUS ITC Europe Surveys: introductory Commentary.

Authors:  Constantine I Vardavas; Christina N Kyriakos; Ann McNeill; Geoffrey T Fong
Journal:  Eur J Public Health       Date:  2020-07-01       Impact factor: 3.367

2.  Smoking cessation behaviors and reasons for use of electronic cigarettes and heated tobacco products among Romanian adults.

Authors:  Sumaira Hussain; Chandrashekhar T Sreeramareddy
Journal:  Sci Rep       Date:  2022-03-31       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.